Women and men experience a similar prevalence of adverse drug reactions in the treatment of coronary artery disease; however, women are significantly less likely than their male counterparts to be treated with statins, aspirin, and beta-blockers according to a new study by researchers at Rush University Medical Center. The study is published in the March issue of the journal Gender Medicine.
“Developments in disease recognition and novel treatment strategies have led to a significant decline in overall cardiovascular death rate among men, but these dramatic improvements have not been observed in women,” said Dr. Jonathan R. Enriquez, lead author of the study and resident internal medicine physician at Rush. “This may be related to underutilization of medical therapies such as aspirin, ß-blockers, ACE inhibitors or statins.”
In association with Dr. Annabelle Volgman and the Rush Heart Center for Women, the study involved 304 consecutive patients with coronary artery disease at the outpatient cardiology clinic at Rush. A retrospective observational analysis was performed to determine the usage and adverse reactions reported from aspirin, ß-blockers, angiotensin-converting-enzyme (ACE) inhibitors or statins. Baseline clinical characteristics were also determined to identify the independent association of gender on usage of standard medical coronary artery disease treatments.
The study found that only 78.1 percent of women were treated with statins compared to 90.8 percent of men. After adjustment for clinical characteristics, men were also found to be six times more likely to receive aspirin and beta-blockers. No significant difference was noted between genders in the prevalence of adverse drug reactions
“The physician’s perception of either anticipated adverse drug reactions or less severe disease may be influencing their decision to not prescribe these medications for women,” said Enriquez. “We encourage further studies to identify the cause of this disparity, so that care for women with coronary artery disease may be optimized.”
Coronary artery disease is the leading-cause of death among women in the United States and annually since 1984 the number of cardiovascular-related deaths in women has exceeded that of men. Women may not only suffer from decreased survival with coronary artery disease, but may also experience a worse quality of life than men.
“Given the findings of this study and other studies documenting the underutilization of current medical therapies in women, we must consider potential solutions to improve care of all patients during the outpatient visit,” said Enriquez.
Source: Rush University Medical Center
Related stories:
New blood clot guidelines for pregnant women
Blood clot recommendations highlight challenges for pediatric and pre-surgery populations
New evidence-based guidelines address the prevention and management of thrombosis in key patient populations and reinforce recommendations related to the routine use of preventive therapies. Published as a supplement in the June issue of
CHEST, the peer-reviewed journal of the American College of Chest Physicians (ACCP), Antithrombotic and Thrombolytic Therapy: ACCP Evidence-Based Clinical Practice Guidelines, Eighth Edition was developed by an international panel of 90 experts and includes more than 700 of the most comprehensive recommendations related to the prevention, treatment, and long-term management of thrombotic disorders. The guidelines include chapters on the challenges in preventing and treating thrombosis in pregnant women and children, and on managing peri- and postoperative patients, while also reinforcing previous guidelines related to the routine use of preventive therapies, including aspirin.
Coronary calcium distribution tied to heart attack risk
A new calcium scoring method may better predict a person’s risk of heart attack, according to a new multicenter study published in the June issue of the journal
Radiology. Calcium coverage scoring takes into account not only the amount of calcified plaque build-up in the coronary arteries, but also its distribution.
Oxidative stress may predict later lung trouble in young adults
Markers of oxidative stress may predict future lung trouble, according to new research to be presented at the American Thoracic Society’s 2008 International Conference in Toronto on Wednesday, May 21.
Patients arriving at hospitals in off hours get slower, less care
Patients hospitalized with heart attacks tend to get faster and more comprehensive care if they arrive during daytime hours, according to a report in Circulation: Journal of the American Heart Association. But, researchers said, variations in care don’t seem to impact in-hospital death rates.
It's neck-and-neck down the long stretch for 2 stroke-prevention procedures
Like horses running down the long stretch of a race track, two different artery-opening treatments appear to be running neck-and-neck when it comes to preventing stroke among people with clogged neck arteries and other health problems.
Gap between sexes in care of common heart condition
Women with a common heart condition may receive a lower level of medical care compared to men with the same condition, according to researchers at the University of Aberdeen.
Coronary calcium testing predicts future heart ailments
Calcium deposits in coronary arteries provide a strong predictor for possible future heart attacks and cardiac diseases, and detecting such deposits can be valuable for promoting overall cardiac health, according to a study led by the University of California, Irvine and appearing in the March 28 issue of the
New England Journal of Medicine.
Oregon study raises questions on synthetic progestins
The widely used synthetic progestin medroxyprogesterone acetate (MPA) decreased endothelial function in premenopausal women in a study done at the University of Oregon. The finding, researchers said, raises concerns about long-term effects of MPA and possibly other synthetic hormones on vascular health in young women.